Novaccess Global (XSNX) Stock Price, News & Analysis
Company Description
Novaccess Global (OTC Link: XSNX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $12.3K.
XSNX has declined 33.3% over the past year. Shares last traded at $0.0002.
For FY2024, Novaccess Global reported revenue of $0 and diluted earnings per share of -$0.06.
This page collects what Stock Titan holds for XSNX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novaccess Global (XSNX) stock last closed at $0.0002. Over the past 12 months, the stock has lost 33.3%. At a market capitalization of $12.3K, XSNX is classified as a micro-cap stock with approximately 61.7M shares outstanding.
XSNX Rankings
Latest News
Novaccess Global has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, management, partnership, AI. View all XSNX news →
SEC Filings
Novaccess Global has filed 1 recent SEC filing, including 1 Form 10-K. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all XSNX SEC filings →
Financial Highlights
Diluted earnings per share stood at -$0.06. The company generated -$215K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Novaccess Global (XSNX) currently stands at 439 shares, down 5.6% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 146.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Novaccess Global (XSNX) currently stands at 146.3 days, up 2856.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 9527% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 146.3 days.
XSNX Company Profile & Sector Positioning
Novaccess Global (XSNX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing XSNX often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), Statera Biopharma Inc (STAB), Renovacare (RCAR), Comera Life (CMRA), and Virpax Pharmaceuticals Inc (VRPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XSNX's relative position within its industry.